1. Home
  2. NAK vs ARDX Comparison

NAK vs ARDX Comparison

Compare NAK & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northern Dynasty Minerals Ltd.

NAK

Northern Dynasty Minerals Ltd.

HOLD

Current Price

$1.33

Market Cap

1.4B

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$6.53

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAK
ARDX
Founded
1983
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2002
2014

Fundamental Metrics

Financial Performance
Metric
NAK
ARDX
Price
$1.33
$6.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$2.50
$14.67
AVG Volume (30 Days)
10.9M
3.8M
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,607,000.00
Revenue This Year
N/A
$35.64
Revenue Next Year
N/A
$34.12
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$3.50
52 Week High
$2.98
$8.40

Technical Indicators

Market Signals
Indicator
NAK
ARDX
Relative Strength Index (RSI) 36.66 45.71
Support Level $0.81 $5.49
Resistance Level $1.59 $6.69
Average True Range (ATR) 0.13 0.36
MACD -0.02 -0.02
Stochastic Oscillator 21.12 56.75

Price Performance

Historical Comparison
NAK
ARDX

About NAK Northern Dynasty Minerals Ltd.

Northern Dynasty Minerals Ltd is a mineral exploration company. It has a single operating segment of acquisition, exploration, and development of mineral properties. Its core asset is the Pebble Project located in Alaska, USA. The Pebble project is seeking to develop a deposit of copper, gold, molybdenum, and silver into a modern mining operation.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: